Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '207600'
    Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences: []
      Name: major histocompatibility complex, class I, B
      Symbol: HLA-B
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences: []
      Name: interleukin 12B
      Symbol: IL12B
  - Gene:
      DisorderGeneAssociationType: Major susceptibility factor in
      ExternalReferences: []
      Name: MAX dimerization protein MLX
      Symbol: MLX
  Label: Takayasu arteritis
  ORPHAcode: '3287'
  ORPHApacketId: '3287'
  PURL: http://www.orpha.net/ORDO/Orphanet_3287
  Parents:
  - Parent:
    - Label: Predominantly large-vessel vasculitis
      ORPHAcode: '156140'
  - Parent:
    - Label: Disease associated with a genetic susceptibility or tested for a biomarker
      ORPHAcode: '231957'
  - Parent:
    - Label: Rare pediatric vasculitis
      ORPHAcode: '280369'
  - Parent:
    - Label: Systemic vasculitis associated with glomerulopathy
      ORPHAcode: '567560'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000975
      HPOTerm: Hyperhidrosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001482
      HPOTerm: Subcutaneous nodule
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001654
      HPOTerm: Abnormal heart valve morphology
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001945
      HPOTerm: Fever
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002617
      HPOTerm: Dilatation
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002633
      HPOTerm: Vasculitis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100545
      HPOTerm: Arterial stenosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100735
      HPOTerm: Hypertensive crisis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000822
      HPOTerm: Hypertension
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001250
      HPOTerm: Seizure
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001324
      HPOTerm: Muscle weakness
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001369
      HPOTerm: Arthritis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001639
      HPOTerm: Hypertrophic cardiomyopathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001646
      HPOTerm: Abnormal aortic valve morphology
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001658
      HPOTerm: Myocardial infarction
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001903
      HPOTerm: Anemia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002039
      HPOTerm: Anorexia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002076
      HPOTerm: Migraine
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002092
      HPOTerm: Pulmonary arterial hypertension
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002793
      HPOTerm: Abnormal pattern of respiration
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003326
      HPOTerm: Myalgia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0004970
      HPOTerm: Ascending tubular aorta aneurysm
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012649
      HPOTerm: Increased inflammatory response
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100533
      HPOTerm: Inflammatory abnormality of the eye
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100749
      HPOTerm: Chest pain
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100758
      HPOTerm: Gangrene
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0200042
      HPOTerm: Skin ulcer
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000488
      HPOTerm: Retinopathy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002105
      HPOTerm: Hemoptysis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002167
      HPOTerm: Neurological speech impairment
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002637
      HPOTerm: Cerebral ischemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002829
      HPOTerm: Arthralgia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0004306
      HPOTerm: Abnormality of the endocardium
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0004372
      HPOTerm: Reduced consciousness/confusion
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0005244
      HPOTerm: Gastrointestinal infarctions
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100576
      HPOTerm: Amaurosis fugax
  Prevalences:
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: ORPHANET_27159262[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: ORPHANET_27159262[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: ORPHANET_19542212[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 9119531[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: ORPHANET_6133485[PMID]_25774057[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: ORPHANET_6133485[PMID]_25774057[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19542212[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21385546[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 15696553[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Kuwait
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 7563255[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 1360971[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 15647446[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Kuwait
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 7563255[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 2858047[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 27159262[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 27159262[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 28283361[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 28283361[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 30260188[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 30260188[PMID
      ValMoy: no data
  TextSection:
    Contents: A rare predominantly large-vessel vasculitis that is characterized by
      affected aorta and its major branches but also other large vessels causing stenosis
      occlusion or aneurysm.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2023
  creationDate: '2023-12-06 11:51:54'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
